04962nam 2200685 450 991081298410332120230807220142.01-118-86327-51-118-86326-71-118-86328-3(CKB)3710000000440565(EBL)2081171(SSID)ssj0001515161(PQKBManifestationID)12621949(PQKBTitleCode)TC0001515161(PQKBWorkID)11481468(PQKB)11575136(PQKBManifestationID)16037134(PQKB)24072398(MiAaPQ)EBC4039372(MiAaPQ)EBC2081171(DLC) 2015007606(Au-PeEL)EBL4039372(CaPaEBR)ebr11112957(CaONFJC)MIL809607(OCoLC)904012321(EXLCZ)99371000000044056520151105h20152015 uy 0engur|||||||||||txtccrClinical guide to transplantation in lymphoma /edited by Bipin N. Savani, MD, Mohamad Mohty, MD, PhDChichester, [England] :Wiley Blackwell,2015.©20151 online resource (288 p.)Description based upon print version of record.1-118-86332-1 Includes bibliographical references at the end of each chapters and index.Title page; Copyright page; Contents; List of contributors; Foreword; Introduction; Declaration of commercial interest; References; Section 1 Transplantation in lymphomas; Chapter 1 Lymphoma and transplantation: historical perspective; Brief history of hematopoietic cell transplantation; History of autologous HCT in non-Hodgkin lymphoma; History of autologous HCT in Hodgkin lymphoma; History of allogeneic HCT in lymphoma; General historical considerations; References; Chapter 2 Lymphoma: working committee and data reporting after transplantation in lymphoma; Introduction; Registry structureWorking committees Data reporting; Overcoming challenges to data reporting; Flow of data; Data quality; The Lymphoma Working Committee; Statistical methods; Type of data; Intervals and patient selection; Unadjusted comparison; Adjusted comparison; Selected examples from the CIBMTR Lymphoma Committee; Value for young investigators; Value for public and other stakeholders; Conclusion; References; Chapter 3 Use of transplantation in lymphoma: adults; Introduction; Hodgkin lymphoma; Non-Hodgkin lymphoma; Diffuse large B-cell lymphoma; Follicular lymphoma; Histologic transformation to DLBCLMantle cell lymphoma Burkitt lymphoma; Primary CNS lymphoma; Peripheral T-cell lymphoma; Prognostic tools; Maintenance therapies; Novel therapies; Conclusions; References; Chapter 4 Hematopoietic stem cell transplantation for lymphoma in children, adolescents, and young adults; Introduction; Principles of autologous and allogeneic HSCT in pediatric lymphomas; Hodgkin lymphoma; Lymphoblastic lymphoma; Anaplastic large-cell lymphoma; Mature B-cell lymphomas: Burkitt lymphoma, diffuse large B-cell lymphoma, and primary mediastinal B-cell lymphoma; Future directions; Conclusions; ReferencesChapter 5 Preparative regimens for lymphoma: autologous hematopoietic stem cell transplantation Rationale for chemotherapy dose intensification for disease eradication; Traditional preparative regimens; Incorporation of monoclonal antibodies in autologous HCT preparative regimens; Rituximab; Monoclonal antibodies conjugated to radionuclide; Novel agents used in preparative regimens; Future directions; References; Chapter 6 Preparative regimens for lymphoma: allogeneic hematopoietic stem cell transplantation; Introduction; Myeloablative conditioning regimens for lymphomasReduced-intensity conditioning regimens RIC allo-HCT in diffuse large B-cell lymphoma; RIC allo-HCT for follicular lymphoma; RIC allo-HCT in mantle cell lymphoma; RIC allo-HCT in Hodgkin lymphoma; Incorporating monoclonal antibodies in preparative regimens for allo-HCT; Alternative donor sources; Umbilical cord blood cells; Haploidentical transplantation; Vaccine strategies in allo-HCT; Discussion and future direction; References; Chapter 7 Pretransplantation evaluation, comorbidities, and nondisease-related eligibility criteria for transplantation in lymphoma; Introduction; Initial stepsPreparation for transplant center evaluationLymphomasSurgeryStem cellsTransplantationLymphomasSurgery.Stem cellsTransplantation.616.99446Savani Bipin N.Mohty MohamadMiAaPQMiAaPQMiAaPQBOOK9910812984103321Clinical guide to transplantation in lymphoma4018578UNINA